vs
Side-by-side financial comparison of M/I HOMES, INC. (MHO) and QuidelOrtho Corp (QDEL). Click either name above to swap in a different company.
M/I HOMES, INC. is the larger business by last-quarter revenue ($1.1B vs $699.9M, roughly 1.6× QuidelOrtho Corp). M/I HOMES, INC. runs the higher net margin — 5.6% vs -104.7%, a 110.3% gap on every dollar of revenue. On growth, QuidelOrtho Corp posted the faster year-over-year revenue change (-3.7% vs -4.8%). M/I HOMES, INC. produced more free cash flow last quarter ($-13.0M vs $-94.7M). Over the past eight quarters, M/I HOMES, INC.'s revenue compounded faster (4.7% CAGR vs -2.9%).
M/I Homes, Inc. is a leading U.S. residential construction company that designs, builds and sells single-family homes, townhomes and duplexes across multiple U.S. states. It caters to entry-level, move-up and luxury homebuyers, offering energy-efficient designs, flexible floor plans and personalized customization options.
QuidelOrtho Corporation is an American manufacturer of diagnostic healthcare products that are sold worldwide.
MHO vs QDEL — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.1B | $699.9M |
| Net Profit | $64.0M | $-733.0M |
| Gross Margin | 17.4% | — |
| Operating Margin | 6.5% | -100.7% |
| Net Margin | 5.6% | -104.7% |
| Revenue YoY | -4.8% | -3.7% |
| Net Profit YoY | -52.1% | -3583.4% |
| EPS (diluted) | $2.42 | $-10.78 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.1B | — | ||
| Q3 25 | $1.1B | $699.9M | ||
| Q2 25 | $1.2B | $613.9M | ||
| Q1 25 | $976.1M | $692.8M | ||
| Q4 24 | $1.2B | $707.8M | ||
| Q3 24 | $1.1B | $727.1M | ||
| Q2 24 | $1.1B | $637.0M | ||
| Q1 24 | $1.0B | $711.0M |
| Q4 25 | $64.0M | — | ||
| Q3 25 | $106.5M | $-733.0M | ||
| Q2 25 | $121.2M | $-255.4M | ||
| Q1 25 | $111.2M | $-12.7M | ||
| Q4 24 | $133.5M | $-178.4M | ||
| Q3 24 | $145.4M | $-19.9M | ||
| Q2 24 | $146.7M | $-147.7M | ||
| Q1 24 | $138.1M | $-1.7B |
| Q4 25 | 17.4% | — | ||
| Q3 25 | 24.5% | — | ||
| Q2 25 | 24.7% | — | ||
| Q1 25 | 25.9% | — | ||
| Q4 24 | 24.6% | — | ||
| Q3 24 | 27.1% | — | ||
| Q2 24 | 27.9% | — | ||
| Q1 24 | 27.1% | — |
| Q4 25 | 6.5% | — | ||
| Q3 25 | 12.0% | -100.7% | ||
| Q2 25 | 13.4% | -29.4% | ||
| Q1 25 | 14.4% | 4.7% | ||
| Q4 24 | 13.6% | -14.2% | ||
| Q3 24 | 15.9% | 2.1% | ||
| Q2 24 | 16.8% | -18.4% | ||
| Q1 24 | 16.6% | -247.3% |
| Q4 25 | 5.6% | — | ||
| Q3 25 | 9.4% | -104.7% | ||
| Q2 25 | 10.4% | -41.6% | ||
| Q1 25 | 11.4% | -1.8% | ||
| Q4 24 | 11.1% | -25.2% | ||
| Q3 24 | 12.7% | -2.7% | ||
| Q2 24 | 13.2% | -23.2% | ||
| Q1 24 | 13.2% | -239.9% |
| Q4 25 | $2.42 | — | ||
| Q3 25 | $3.92 | $-10.78 | ||
| Q2 25 | $4.42 | $-3.77 | ||
| Q1 25 | $3.98 | $-0.19 | ||
| Q4 24 | $4.71 | $-2.54 | ||
| Q3 24 | $5.10 | $-0.30 | ||
| Q2 24 | $5.12 | $-2.20 | ||
| Q1 24 | $4.78 | $-25.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $98.1M |
| Total DebtLower is stronger | — | $2.5B |
| Stockholders' EquityBook value | $3.2B | $2.0B |
| Total Assets | $4.8B | $5.7B |
| Debt / EquityLower = less leverage | — | 1.23× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | $98.1M | ||
| Q2 25 | — | $151.7M | ||
| Q1 25 | — | $127.1M | ||
| Q4 24 | — | $98.3M | ||
| Q3 24 | — | $143.7M | ||
| Q2 24 | — | $107.0M | ||
| Q1 24 | — | $78.5M |
| Q4 25 | — | — | ||
| Q3 25 | — | $2.5B | ||
| Q2 25 | — | $2.1B | ||
| Q1 25 | — | $2.1B | ||
| Q4 24 | — | $2.1B | ||
| Q3 24 | — | $2.2B | ||
| Q2 24 | — | $2.2B | ||
| Q1 24 | — | $2.2B |
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.1B | $2.0B | ||
| Q2 25 | $3.1B | $2.8B | ||
| Q1 25 | $3.0B | $3.0B | ||
| Q4 24 | $2.9B | $3.0B | ||
| Q3 24 | $2.8B | $3.2B | ||
| Q2 24 | $2.7B | $3.2B | ||
| Q1 24 | $2.6B | $3.3B |
| Q4 25 | $4.8B | — | ||
| Q3 25 | $4.8B | $5.7B | ||
| Q2 25 | $4.7B | $6.4B | ||
| Q1 25 | $4.6B | $6.5B | ||
| Q4 24 | $4.5B | $6.4B | ||
| Q3 24 | $4.5B | $6.8B | ||
| Q2 24 | $4.3B | $6.7B | ||
| Q1 24 | $4.2B | $6.7B |
| Q4 25 | — | — | ||
| Q3 25 | — | 1.23× | ||
| Q2 25 | — | 0.74× | ||
| Q1 25 | — | 0.70× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.68× | ||
| Q2 24 | — | 0.70× | ||
| Q1 24 | — | 0.68× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-8.7M | $-45.5M |
| Free Cash FlowOCF − Capex | $-13.0M | $-94.7M |
| FCF MarginFCF / Revenue | -1.1% | -13.5% |
| Capex IntensityCapex / Revenue | 0.4% | 7.0% |
| Cash ConversionOCF / Net Profit | -0.14× | — |
| TTM Free Cash FlowTrailing 4 quarters | $127.7M | $-153.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-8.7M | — | ||
| Q3 25 | $43.4M | $-45.5M | ||
| Q2 25 | $37.8M | $-46.8M | ||
| Q1 25 | $64.9M | $65.6M | ||
| Q4 24 | $104.4M | $63.7M | ||
| Q3 24 | $-67.9M | $117.9M | ||
| Q2 24 | $27.5M | $-97.9M | ||
| Q1 24 | $115.8M | $-700.0K |
| Q4 25 | $-13.0M | — | ||
| Q3 25 | $42.0M | $-94.7M | ||
| Q2 25 | $35.1M | $-84.3M | ||
| Q1 25 | $63.5M | $9.4M | ||
| Q4 24 | $102.3M | $16.5M | ||
| Q3 24 | $-68.5M | $71.4M | ||
| Q2 24 | $22.0M | $-133.2M | ||
| Q1 24 | $115.5M | $-66.8M |
| Q4 25 | -1.1% | — | ||
| Q3 25 | 3.7% | -13.5% | ||
| Q2 25 | 3.0% | -13.7% | ||
| Q1 25 | 6.5% | 1.4% | ||
| Q4 24 | 8.5% | 2.3% | ||
| Q3 24 | -6.0% | 9.8% | ||
| Q2 24 | 2.0% | -20.9% | ||
| Q1 24 | 11.0% | -9.4% |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | 7.0% | ||
| Q2 25 | 0.2% | 6.1% | ||
| Q1 25 | 0.1% | 8.1% | ||
| Q4 24 | 0.2% | 6.7% | ||
| Q3 24 | 0.1% | 6.4% | ||
| Q2 24 | 0.5% | 5.5% | ||
| Q1 24 | 0.0% | 9.3% |
| Q4 25 | -0.14× | — | ||
| Q3 25 | 0.41× | — | ||
| Q2 25 | 0.31× | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | -0.47× | — | ||
| Q2 24 | 0.19× | — | ||
| Q1 24 | 0.84× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MHO
| Southern Homebuilding | $615.6M | 54% |
| Northern Homebuilding | $503.9M | 44% |
| Financial Service | $27.8M | 2% |
| Land | $4.7M | 0% |
QDEL
| Labs | $373.8M | 53% |
| Point Of Care | $164.6M | 24% |
| Immunohematology | $142.0M | 20% |
| Donor Screening | $14.7M | 2% |
| Molecular Diagnostics | $4.8M | 1% |
| Collaborative Arrangement Transaction With Party To Collaborative Arrangement | $2.1M | 0% |
